MedTrace Logo

Symptom-Based Markers for COVID-19 Transmission

NCT04665245 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 214

Last updated 2026-01-26

Study results available
· View outcomes & findings →

Summary

In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.

Conditions

  • Covid19

Sponsors & Collaborators

  • University of Iowa

    lead OTHER

Principal Investigators

  • Alberto M Segre, PhD · University of Iowa

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-05-19
Completion
2021-05-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04665245 on ClinicalTrials.gov